Aug. 17 at 5:23 AM
$IKT - Inhibikase Therapeutics, Inc. - 10Q - Updated Risk Factors
IKT flags new risks from potential healthcare cost-cutting laws and U.S. tax changes, plus updates on trade uncertainty and tariffs impacting raw materials despite pharma product exemptions. #Biotechnology #Pharmaceuticals #TradeUncertainty #TaxRisk #HealthcareCosts
🟢 Added 🟠 Removed
https://d-risk.ai/IKT/10-Q/2025-08-14